Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) was up 1,346.6% during trading on Friday . The stock traded as high as $0.45 and last traded at $0.45. Approximately 97 shares traded hands during trading, a decline of 100% from the average daily volume of 20,342 shares. The stock had previously closed at $0.03.
Cell MedX Trading Up 1,346.6 %
The firm’s 50-day moving average price is $0.09 and its two-hundred day moving average price is $0.05.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Read More
- Five stocks we like better than Cell MedX
- 5 discounted opportunities for dividend growth investors
- Tesla Investors Continue to Profit From the Trump Trade
- What is MarketRank™? How to Use it
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
